Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Blood Disorder Drug Maker Acquired in $11.6B Deal

The global pharmaceutical company Sanofi is buying Bioverativ Inc., a developer of biologics to treat hemophilia and other rare blood disorders. . . . → Read More: Blood Disorder Drug Maker Acquired in $11.6B Deal

Stem Cells Created with Gene Editing

A research lab in San Francisco devised a simpler process for creating stem cells from skin cells in mice with the gene editing technique Crispr. . . . → Read More: Stem Cells Created with Gene Editing

Technique Developed for High-Speed Antibody Screening

A process is being developed to quickly discover antibodies in a person’s immune system that can also lead to new vaccines and drugs against viruses. . . . → Read More: Technique Developed for High-Speed Antibody Screening

Components Designed to Improve Genetic Circuits

Researchers in Houston, Texas created a set of components like those in electronics that help make synthetic gene circuits more accurate and predictable. . . . → Read More: Components Designed to Improve Genetic Circuits

First MERS Virus Treatment Found Safe

An experimental treatment for Middle East respiratory syndrome, or MERS, infections made from antibodies produced in cattle is shown in a clinical trial to be safe for patients. . . . → Read More: First MERS Virus Treatment Found Safe

Genomic Analysis Company Adds Body Composition Profiles

A company analyzing genomics and microbiome factors to extend human life spans is adding an evaluation of body composition to its tool kit. . . . → Read More: Genomic Analysis Company Adds Body Composition Profiles

Biotech, Microsoft Partner on Immune System Diagnostics

A company that analyzes immune system genomics is collaborating with Microsoft Corporation to develop early-stage disease diagnostics. . . . → Read More: Biotech, Microsoft Partner on Immune System Diagnostics

Sangamo, Pfizer Partner on ALS Gene Therapy

Drug maker Pfizer Inc. is licensing and collaborating on a gene therapy technology from Sangamo Therapeutics Inc. to treat amyotrophic lateral sclerosis, or ALS, and a related neurodegenerative disease. . . . → Read More: Sangamo, Pfizer Partner on ALS Gene Therapy

RNA Therapies Start-Up Raises $55.3M in Early Funds

A start-up company creating treatments for inherited diseases that target faulty RNA transcribed from genetic codes is raising $55.3 million in its first venture funding round. . . . → Read More: RNA Therapies Start-Up Raises $55.3M in Early Funds

Techniques Devised to Speed-Up Plant Breeding

Plant scientists in Australia and the U.K. developed a process that sharply cuts the amount of time needed to produce new breeds of plant crops including commercial varieties of wheat. . . . → Read More: Techniques Devised to Speed-Up Plant Breeding